Global Oral Transmucosal Drugs Market Growth 2021-2026
According to this latest study, the 2021 growth of Oral Transmucosal Drugs will have significant change from previous year. By the most conservative estimates of global Oral Transmucosal Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX million in 2020. Over the next five years the Oral Transmucosal Drugs market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Transmucosal Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Tablets
Films
Liquid Spray
Gels
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Cardiovascular Disorders
Acute Pain Managements
Diabetes
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
LTS Lohmann Therapie-Systeme AG
Soligenix
ZIM Laboratories Limited
Access Pharmaceutical Inc.
C.L Pharm
Cure Pharmaceutical
Aquestive Therapeutics, Inc.
NAL Pharma
IntelGenx Corp.
Eisai Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.
Teva Pharmaceutical Industries Ltd.
GlaxoSmithKline plc
Viatris
Bristol-Myers Squibb Company
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Transmucosal Drugs Consumption 2016-2026
2.1.2 Oral Transmucosal Drugs Consumption CAGR by Region
2.2 Oral Transmucosal Drugs Segment by Type
2.2.1 Tablets
2.2.2 Films
2.2.3 Liquid Spray
2.2.4 Gels
2.2.5 Others
2.3 Oral Transmucosal Drugs Sales by Type
2.3.1 Global Oral Transmucosal Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Oral Transmucosal Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Oral Transmucosal Drugs Sale Price by Type (2016-2021)
2.4 Oral Transmucosal Drugs Segment by Application
2.4.1 Cardiovascular Disorders
2.4.2 Acute Pain Managements
2.4.3 Diabetes
2.4.4 Others
2.5 Oral Transmucosal Drugs Sales by Application
2.5.1 Global Oral Transmucosal Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Oral Transmucosal Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Oral Transmucosal Drugs Sale Price by Application (2016-2021)
3 Global Oral Transmucosal Drugs by Company
3.1 Global Oral Transmucosal Drugs Sales Market Share by Company
3.1.1 Global Oral Transmucosal Drugs Sales by Company (2019-2021)
3.1.2 Global Oral Transmucosal Drugs Sales Market Share by Company (2019-2021)
3.2 Global Oral Transmucosal Drugs Revenue Market Share by Company
3.2.1 Global Oral Transmucosal Drugs Revenue by Company (2019-2021)
3.2.2 Global Oral Transmucosal Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Oral Transmucosal Drugs Sale Price by Company
3.4 Global Manufacturers Oral Transmucosal Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Transmucosal Drugs Product Location Distribution
3.4.2 Players Oral Transmucosal Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Oral Transmucosal Drugs by Region
4.1 Global Oral Transmucosal Drugs by Region
4.1.1 Global Oral Transmucosal Drugs Sales by Region
4.1.2 Global Oral Transmucosal Drugs Revenue by Region
4.2 Americas Oral Transmucosal Drugs Sales Growth
4.3 APAC Oral Transmucosal Drugs Sales Growth
4.4 Europe Oral Transmucosal Drugs Sales Growth
4.5 Middle East & Africa Oral Transmucosal Drugs Sales Growth
5 Americas
5.1 Americas Oral Transmucosal Drugs Sales by Country
5.1.1 Americas Oral Transmucosal Drugs Sales by Country (2016-2021)
5.1.2 Americas Oral Transmucosal Drugs Revenue by Country (2016-2021)
5.2 Americas Oral Transmucosal Drugs Sales by Type
5.3 Americas Oral Transmucosal Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Transmucosal Drugs Sales by Region
6.1.1 APAC Oral Transmucosal Drugs Sales by Region (2016-2021)
6.1.2 APAC Oral Transmucosal Drugs Revenue by Region (2016-2021)
6.2 APAC Oral Transmucosal Drugs Sales by Type
6.3 APAC Oral Transmucosal Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Oral Transmucosal Drugs by Country
7.1.1 Europe Oral Transmucosal Drugs Sales by Country (2016-2021)
7.1.2 Europe Oral Transmucosal Drugs Revenue by Country (2016-2021)
7.2 Europe Oral Transmucosal Drugs Sales by Type
7.3 Europe Oral Transmucosal Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Transmucosal Drugs by Country
8.1.1 Middle East & Africa Oral Transmucosal Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Oral Transmucosal Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Oral Transmucosal Drugs Sales by Type
8.3 Middle East & Africa Oral Transmucosal Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Oral Transmucosal Drugs Distributors
10.3 Oral Transmucosal Drugs Customer
11 Global Oral Transmucosal Drugs Market Forecast
11.1 Global Oral Transmucosal Drugs Forecast by Region
11.1.1 Global Oral Transmucosal Drugs Forecast by Regions (2021-2026)
11.2.2 Global Oral Transmucosal Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Oral Transmucosal Drugs Forecast by Type
11.7 Global Oral Transmucosal Drugs Forecast by Application
12 Key Players Analysis
12.1 LTS Lohmann Therapie-Systeme AG
12.1.1 LTS Lohmann Therapie-Systeme AG Company Information
12.1.2 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product Offered
12.1.3 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 LTS Lohmann Therapie-Systeme AG Main Business Overview
12.1.5 LTS Lohmann Therapie-Systeme AG Latest Developments
12.2 Soligenix
12.2.1 Soligenix Company Information
12.2.2 Soligenix Oral Transmucosal Drugs Product Offered
12.2.3 Soligenix Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Soligenix Main Business Overview
12.2.5 Soligenix Latest Developments
12.3 ZIM Laboratories Limited
12.3.1 ZIM Laboratories Limited Company Information
12.3.2 ZIM Laboratories Limited Oral Transmucosal Drugs Product Offered
12.3.3 ZIM Laboratories Limited Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 ZIM Laboratories Limited Main Business Overview
12.3.5 ZIM Laboratories Limited Latest Developments
12.4 Access Pharmaceutical Inc.
12.4.1 Access Pharmaceutical Inc. Company Information
12.4.2 Access Pharmaceutical Inc. Oral Transmucosal Drugs Product Offered
12.4.3 Access Pharmaceutical Inc. Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Access Pharmaceutical Inc. Main Business Overview
12.4.5 Access Pharmaceutical Inc. Latest Developments
12.5 C.L Pharm
12.5.1 C.L Pharm Company Information
12.5.2 C.L Pharm Oral Transmucosal Drugs Product Offered
12.5.3 C.L Pharm Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 C.L Pharm Main Business Overview
12.5.5 C.L Pharm Latest Developments
12.6 Cure Pharmaceutical
12.6.1 Cure Pharmaceutical Company Information
12.6.2 Cure Pharmaceutical Oral Transmucosal Drugs Product Offered
12.6.3 Cure Pharmaceutical Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Cure Pharmaceutical Main Business Overview
12.6.5 Cure Pharmaceutical Latest Developments
12.7 Aquestive Therapeutics, Inc.
12.7.1 Aquestive Therapeutics, Inc. Company Information
12.7.2 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product Offered
12.7.3 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Aquestive Therapeutics, Inc. Main Business Overview
12.7.5 Aquestive Therapeutics, Inc. Latest Developments
12.8 NAL Pharma
12.8.1 NAL Pharma Company Information
12.8.2 NAL Pharma Oral Transmucosal Drugs Product Offered
12.8.3 NAL Pharma Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 NAL Pharma Main Business Overview
12.8.5 NAL Pharma Latest Developments
12.9 IntelGenx Corp.
12.9.1 IntelGenx Corp. Company Information
12.9.2 IntelGenx Corp. Oral Transmucosal Drugs Product Offered
12.9.3 IntelGenx Corp. Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 IntelGenx Corp. Main Business Overview
12.9.5 IntelGenx Corp. Latest Developments
12.10 Eisai Co., Ltd.
12.10.1 Eisai Co., Ltd. Company Information
12.10.2 Eisai Co., Ltd. Oral Transmucosal Drugs Product Offered
12.10.3 Eisai Co., Ltd. Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Eisai Co., Ltd. Main Business Overview
12.10.5 Eisai Co., Ltd. Latest Developments
12.11 Otsuka Pharmaceutical Co., Ltd.
12.11.1 Otsuka Pharmaceutical Co., Ltd. Company Information
12.11.2 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product Offered
12.11.3 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Otsuka Pharmaceutical Co., Ltd. Main Business Overview
12.11.5 Otsuka Pharmaceutical Co., Ltd. Latest Developments
12.12 Teva Pharmaceutical Industries Ltd.
12.12.1 Teva Pharmaceutical Industries Ltd. Company Information
12.12.2 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product Offered
12.12.3 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
12.12.5 Teva Pharmaceutical Industries Ltd. Latest Developments
12.13 GlaxoSmithKline plc
12.13.1 GlaxoSmithKline plc Company Information
12.13.2 GlaxoSmithKline plc Oral Transmucosal Drugs Product Offered
12.13.3 GlaxoSmithKline plc Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 GlaxoSmithKline plc Main Business Overview
12.13.5 GlaxoSmithKline plc Latest Developments
12.14 Viatris
12.14.1 Viatris Company Information
12.14.2 Viatris Oral Transmucosal Drugs Product Offered
12.14.3 Viatris Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Viatris Main Business Overview
12.14.5 Viatris Latest Developments
12.15 Bristol-Myers Squibb Company
12.15.1 Bristol-Myers Squibb Company Company Information
12.15.2 Bristol-Myers Squibb Company Oral Transmucosal Drugs Product Offered
12.15.3 Bristol-Myers Squibb Company Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Bristol-Myers Squibb Company Main Business Overview
12.15.5 Bristol-Myers Squibb Company Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Oral Transmucosal Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Tablets
Table 3. Major Players of Films
Table 4. Major Players of Liquid Spray
Table 5. Major Players of Gels
Table 6. Major Players of Others
Table 7. Global Oral Transmucosal Drugs Sales by Type (2016-2021) & (K Units)
Table 8. Global Oral Transmucosal Drugs Sales Market Share by Type (2016-2021)
Table 9. Global Oral Transmucosal Drugs Revenue by Type (2016-2021) & ($ million)
Table 10. Global Oral Transmucosal Drugs Revenue Market Share by Type (2016-2021)
Table 11. Global Oral Transmucosal Drugs Sale Price by Type (2016-2021)
Table 12. Global Oral Transmucosal Drugs Sales by Application (2016-2021) & (K Units)
Table 13. Global Oral Transmucosal Drugs Sales Market Share by Application (2016-2021)
Table 14. Global Oral Transmucosal Drugs Value by Application (2016-2021)
Table 15. Global Oral Transmucosal Drugs Revenue Market Share by Application (2016-2021)
Table 16. Global Oral Transmucosal Drugs Sale Price by Application (2016-2021)
Table 17. Global Oral Transmucosal Drugs Sales by Company (2019-2021) & (K Units)
Table 18. Global Oral Transmucosal Drugs Sales Market Share by Company (2019-2021)
Table 19. Global Oral Transmucosal Drugs Revenue by Company (2019-2021) ($ Millions)
Table 20. Global Oral Transmucosal Drugs Revenue Market Share by Company (2019-2021)
Table 21. Global Oral Transmucosal Drugs Sale Price by Company (2019-2021)
Table 22. Key Manufacturers Oral Transmucosal Drugs Producing Area Distribution and Sales Area
Table 23. Players Oral Transmucosal Drugs Products Offered
Table 24. Oral Transmucosal Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Oral Transmucosal Drugs Sales by Region (2016-2021) (K Units)
Table 28. Global Oral Transmucosal Drugs Sales Market Share by Region (2016-2021)
Table 29. Global Oral Transmucosal Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 30. Global Oral Transmucosal Drugs Revenue Market Share by Region (2016-2021)
Table 31. Americas Oral Transmucosal Drugs Sales by Country (2016-2021) & (K Units)
Table 32. Americas Oral Transmucosal Drugs Sales Market Share by Country (2016-2021)
Table 33. Americas Oral Transmucosal Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 34. Americas Oral Transmucosal Drugs Revenue Market Share by Country (2016-2021)
Table 35. Americas Oral Transmucosal Drugs Sales by Type (2016-2021) & (K Units)
Table 36. Americas Oral Transmucosal Drugs Sales Market Share by Type (2016-2021)
Table 37. Americas Oral Transmucosal Drugs Sales by Application (2016-2021) & (K Units)
Table 38. Americas Oral Transmucosal Drugs Sales Market Share by Application (2016-2021)
Table 39. APAC Oral Transmucosal Drugs Sales by Region (2016-2021) & (K Units)
Table 40. APAC Oral Transmucosal Drugs Sales Market Share by Region (2016-2021)
Table 41. APAC Oral Transmucosal Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 42. APAC Oral Transmucosal Drugs Revenue Market Share by Region (2016-2021)
Table 43. APAC Oral Transmucosal Drugs Sales by Type (2016-2021) & (K Units)
Table 44. APAC Oral Transmucosal Drugs Sales Market Share by Type (2016-2021)
Table 45. APAC Oral Transmucosal Drugs Sales by Application (2016-2021) & (K Units)
Table 46. APAC Oral Transmucosal Drugs Sales Market Share by Application (2016-2021)
Table 47. Europe Oral Transmucosal Drugs Sales by Country (2016-2021) & (K Units)
Table 48. Europe Oral Transmucosal Drugs Sales Market Share by Country (2016-2021)
Table 49. Europe Oral Transmucosal Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 50. Europe Oral Transmucosal Drugs Revenue Market Share by Country (2016-2021)
Table 51. Europe Oral Transmucosal Drugs Sales by Type (2016-2021) & (K Units)
Table 52. Europe Oral Transmucosal Drugs Sales Market Share by Type (2016-2021)
Table 53. Europe Oral Transmucosal Drugs Sales by Application (2016-2021) & (K Units)
Table 54. Europe Oral Transmucosal Drugs Sales Market Share by Application (2016-2021)
Table 55. Middle East & Africa Oral Transmucosal Drugs Sales by Country (2016-2021) & (K Units)
Table 56. Middle East & Africa Oral Transmucosal Drugs Sales Market Share by Country (2016-2021)
Table 57. Middle East & Africa Oral Transmucosal Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 58. Middle East & Africa Oral Transmucosal Drugs Revenue Market Share by Country (2016-2021)
Table 59. Middle East & Africa Oral Transmucosal Drugs Sales by Type (2016-2021) & (K Units)
Table 60. Middle East & Africa Oral Transmucosal Drugs Sales Market Share by Type (2016-2021)
Table 61. Middle East & Africa Oral Transmucosal Drugs Sales by Application (2016-2021) & (K Units)
Table 62. Middle East & Africa Oral Transmucosal Drugs Sales Market Share by Application (2016-2021)
Table 63. Key and Potential Regions of Oral Transmucosal Drugs
Table 64. Key Application and Potential Industries of Oral Transmucosal Drugs
Table 65. Key Challenges of Oral Transmucosal Drugs
Table 66. Key Trends of Oral Transmucosal Drugs
Table 67. Oral Transmucosal Drugs Distributors List
Table 68. Oral Transmucosal Drugs Customer List
Table 69. Global Oral Transmucosal Drugs Sales Forecast by Region (2021-2026) & (K Units)
Table 70. Global Oral Transmucosal Drugs Consumption Market Forecast by Region
Table 71. Global Oral Transmucosal Drugs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 72. Global Oral Transmucosal Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 73. Americas Oral Transmucosal Drugs Sales Forecast by Country (2021-2026) & (K Units)
Table 74. Americas Oral Transmucosal Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 75. APAC Oral Transmucosal Drugs Sales Forecast by Region (2021-2026) & (K Units)
Table 76. APAC Oral Transmucosal Drugs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 77. Europe Oral Transmucosal Drugs Sales Forecast by Country (2021-2026) & (K Units)
Table 78. Europe Oral Transmucosal Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Middle East & Africa Oral Transmucosal Drugs Sales Forecast by Country (2021-2026) & (K Units)
Table 80. Middle East & Africa Oral Transmucosal Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 81. Global Oral Transmucosal Drugs Sales Forecast by Type (2021-2026) & (K Units)
Table 82. Global Oral Transmucosal Drugs Sales Market Share Forecast by Type (2021-2026)
Table 83. Global Oral Transmucosal Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 84. Global Oral Transmucosal Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 85. Global Oral Transmucosal Drugs Sales Forecast by Application (2021-2026) & (K Units)
Table 86. Global Oral Transmucosal Drugs Sales Market Share Forecast by Application (2021-2026)
Table 87. Global Oral Transmucosal Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 88. Global Oral Transmucosal Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 89. LTS Lohmann Therapie-Systeme AG Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product Offered
Table 91. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 92. LTS Lohmann Therapie-Systeme AG Main Business
Table 93. LTS Lohmann Therapie-Systeme AG Latest Developments
Table 94. Soligenix Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Soligenix Oral Transmucosal Drugs Product Offered
Table 96. Soligenix Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 97. Soligenix Main Business
Table 98. Soligenix Latest Developments
Table 99. ZIM Laboratories Limited Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. ZIM Laboratories Limited Oral Transmucosal Drugs Product Offered
Table 101. ZIM Laboratories Limited Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 102. ZIM Laboratories Limited Main Business
Table 103. ZIM Laboratories Limited Latest Developments
Table 104. Access Pharmaceutical Inc. Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Access Pharmaceutical Inc. Oral Transmucosal Drugs Product Offered
Table 106. Access Pharmaceutical Inc. Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 107. Access Pharmaceutical Inc. Main Business
Table 108. Access Pharmaceutical Inc. Latest Developments
Table 109. C.L Pharm Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. C.L Pharm Oral Transmucosal Drugs Product Offered
Table 111. C.L Pharm Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 112. C.L Pharm Main Business
Table 113. C.L Pharm Latest Developments
Table 114. Cure Pharmaceutical Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Cure Pharmaceutical Oral Transmucosal Drugs Product Offered
Table 116. Cure Pharmaceutical Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 117. Cure Pharmaceutical Main Business
Table 118. Cure Pharmaceutical Latest Developments
Table 119. Aquestive Therapeutics, Inc. Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product Offered
Table 121. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 122. Aquestive Therapeutics, Inc. Main Business
Table 123. Aquestive Therapeutics, Inc. Latest Developments
Table 124. NAL Pharma Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. NAL Pharma Oral Transmucosal Drugs Product Offered
Table 126. NAL Pharma Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 127. NAL Pharma Main Business
Table 128. NAL Pharma Latest Developments
Table 129. IntelGenx Corp. Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. IntelGenx Corp. Oral Transmucosal Drugs Product Offered
Table 131. IntelGenx Corp. Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 132. IntelGenx Corp. Main Business
Table 133. IntelGenx Corp. Latest Developments
Table 134. Eisai Co., Ltd. Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. Eisai Co., Ltd. Oral Transmucosal Drugs Product Offered
Table 136. Eisai Co., Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 137. Eisai Co., Ltd. Main Business
Table 138. Eisai Co., Ltd. Latest Developments
Table 139. Otsuka Pharmaceutical Co., Ltd. Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 140. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product Offered
Table 141. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 142. Otsuka Pharmaceutical Co., Ltd. Main Business
Table 143. Otsuka Pharmaceutical Co., Ltd. Latest Developments
Table 144. Teva Pharmaceutical Industries Ltd. Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 145. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product Offered
Table 146. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 147. Teva Pharmaceutical Industries Ltd. Main Business
Table 148. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 149. GlaxoSmithKline plc Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 150. GlaxoSmithKline plc Oral Transmucosal Drugs Product Offered
Table 151. GlaxoSmithKline plc Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 152. GlaxoSmithKline plc Main Business
Table 153. GlaxoSmithKline plc Latest Developments
Table 154. Viatris Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 155. Viatris Oral Transmucosal Drugs Product Offered
Table 156. Viatris Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 157. Viatris Main Business
Table 158. Viatris Latest Developments
Table 159. Bristol-Myers Squibb Company Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 160. Bristol-Myers Squibb Company Oral Transmucosal Drugs Product Offered
Table 161. Bristol-Myers Squibb Company Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 162. Bristol-Myers Squibb Company Main Business
Table 163. Bristol-Myers Squibb Company Latest Developments
List of Figures
Figure 1. Picture of Oral Transmucosal Drugs
Figure 2. Oral Transmucosal Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Transmucosal Drugs Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Oral Transmucosal Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Oral Transmucosal Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Tablets
Figure 10. Product Picture of Films
Figure 11. Product Picture of Liquid Spray
Figure 12. Product Picture of Gels
Figure 13. Product Picture of Others
Figure 14. Global Oral Transmucosal Drugs Sales Market Share by Type in 2020
Figure 15. Global Oral Transmucosal Drugs Revenue Market Share by Type (2016-2021)
Figure 16. Oral Transmucosal Drugs Consumed in Cardiovascular Disorders
Figure 17. Global Oral Transmucosal Drugs Market: Cardiovascular Disorders (2016-2021) & (K Units)
Figure 18. Oral Transmucosal Drugs Consumed in Acute Pain Managements
Figure 19. Global Oral Transmucosal Drugs Market: Acute Pain Managements (2016-2021) & (K Units)
Figure 20. Oral Transmucosal Drugs Consumed in Diabetes
Figure 21. Global Oral Transmucosal Drugs Market: Diabetes (2016-2021) & (K Units)
Figure 22. Oral Transmucosal Drugs Consumed in Others
Figure 23. Global Oral Transmucosal Drugs Market: Others (2016-2021) & (K Units)
Figure 24. Global Oral Transmucosal Drugs Sales Market Share by Application (2016-2021)
Figure 25. Global Oral Transmucosal Drugs Revenue Market Share by Application in 2020
Figure 26. Oral Transmucosal Drugs Revenue Market by Company in 2020 ($ Million)
Figure 27. Global Oral Transmucosal Drugs Revenue Market Share by Company in 2020
Figure 28. Global Oral Transmucosal Drugs Sales Market Share by Regions (2016-2021)
Figure 29. Global Oral Transmucosal Drugs Revenue Market Share by Region in 2020
Figure 30. Americas Oral Transmucosal Drugs Sales 2016-2021 (K Units)
Figure 31. Americas Oral Transmucosal Drugs Revenue 2016-2021 ($ Millions)
Figure 32. APAC Oral Transmucosal Drugs Sales 2016-2021 (K Units)
Figure 33. APAC Oral Transmucosal Drugs Revenue 2016-2021 ($ Millions)
Figure 34. Europe Oral Transmucosal Drugs Sales 2016-2021 (K Units)
Figure 35. Europe Oral Transmucosal Drugs Revenue 2016-2021 ($ Millions)
Figure 36. Middle East & Africa Oral Transmucosal Drugs Sales 2016-2021 (K Units)
Figure 37. Middle East & Africa Oral Transmucosal Drugs Revenue 2016-2021 ($ Millions)
Figure 38. Americas Oral Transmucosal Drugs Sales Market Share by Country in 2020
Figure 39. Americas Oral Transmucosal Drugs Revenue Market Share by Country in 2020
Figure 40. Americas Oral Transmucosal Drugs Sales Market Share by Type in 2020
Figure 41. Americas Oral Transmucosal Drugs Sales Market Share by Application in 2020
Figure 42. United States Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 43. Canada Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 44. Mexico Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 45. Brazil Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 46. APAC Oral Transmucosal Drugs Sales Market Share by Region in 2020
Figure 47. APAC Oral Transmucosal Drugs Revenue Market Share by Regions in 2020
Figure 48. APAC Oral Transmucosal Drugs Sales Market Share by Type in 2020
Figure 49. APAC Oral Transmucosal Drugs Sales Market Share by Application in 2020
Figure 50. China Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 51. Japan Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 52. Korea Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 53. Southeast Asia Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 54. India Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 55. Australia Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 56. Europe Oral Transmucosal Drugs Sales Market Share by Country in 2020
Figure 57. Europe Oral Transmucosal Drugs Revenue Market Share by Country in 2020
Figure 58. Europe Oral Transmucosal Drugs Sales Market Share by Type in 2020
Figure 59. Europe Oral Transmucosal Drugs Sales Market Share by Application in 2020
Figure 60. Germany Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 61. France Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 62. UK Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 63. Italy Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 64. Russia Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 65. Middle East & Africa Oral Transmucosal Drugs Sales Market Share by Country in 2020
Figure 66. Middle East & Africa Oral Transmucosal Drugs Revenue Market Share by Country in 2020
Figure 67. Middle East & Africa Oral Transmucosal Drugs Sales Market Share by Type in 2020
Figure 68. Middle East & Africa Oral Transmucosal Drugs Sales Market Share by Application in 2020
Figure 69. Egypt Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 70. South Africa Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 71. Israel Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 72. Turkey Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 73. GCC Country Oral Transmucosal Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
